Darren Keamy
Fortuna: 2 M $ al 30/06/2026
Fortuna: 2 M $ al 30/06/2026
Darren M.
Keamy currently works at Imugene Ltd., as Chief Financial Officer & Secretary from 2025.
Mr. Keamy also formerly worked at Clinuvel Pharmaceuticals Ltd., as Chief Financial Officer in 2024.
Mr. Keamy received his undergraduate degree from La Trobe University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/08/2025 | 242.890 ( 0,48 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMUGENE LIMITED | Director Financiero/CFO | 04/03/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Director Financiero/CFO | 30/06/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Imugene Ltd.
Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
LaTrobe University
LaTrobe University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.